Home » FDA, AHRQ Announce Public RiskMAPs Workshop
News
Posted On: 05/23/2007
FDA, AHRQ Announce Public RiskMAPs Workshop
PharmaManufacturing.com
The Agency for Healthcare Research and Quality (AHRQ) and FDA are announcing a 2-day joint public workshop entitled "Implementation of Risk Minimization Action Plans (RiskMAPs) to Support Quality Use of Pharmaceuticals: Opportunities and Challenges." The purpose of the public workshop is to get constructive input from a wide range of stakeholders, including clinicians, pharmacists, patients, third party payers of care, the pharmaceutical and biotechnology industries, researchers, and innovators in health information technology, to help in the development and implementation of mechanisms to minimize the risks of pharmaceuticals with unusual safety and patient monitoring concerns.
The public workshop will be held on June 25 and 26, 2007, from 8:30 a.m. to 5 p.m. Copy and paste the entire link below into your web browser for information on how to register to attend or present at the meeting. June 4, 2007, is the registration deadline to attend or participate in the workshop.
a257.g.akamaitech.net/7/257/2422/01jan20071800/edocket.access.gpo.gov/2007/07-2574.htm